Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer.

Anupong SawasdeeMonthira TanthanuchTanan Bejrananda

Published in: Asian Pacific journal of cancer prevention : APJCP (2022)

The overall survival of neoadjuvant chemotherapy (NAC) was better than adjuvant chemotherapy (AC) in regards to muscle-invasive bladder cancer. These data could support the use of neoadjuvant chemotherapy in MIBC prior to radical cystectomy.

Keyphrases

muscle invasive bladder cancer
neoadjuvant chemotherapy
locally advanced
rectal cancer
squamous cell carcinoma
lymph node
radiation therapy
sentinel lymph node
transcription factor
electronic health record
big data
free survival